MASH cirrhosis has traditionally been considered irreversible. However, new data from investigators at Cleveland Clinic, presented at Digestive Disease Week 2026, demonstrate that cirrhosis regression can occur following metabolic and bariatric surgery (MBS). In a retrospective cohort of patients with biopsy-proven compensated MASH cirrhosis undergoing…
The U.S. healthcare system is approaching a tipping point, driven by three converging threats: rising care costs, a growing chronic…
In a bid to close persistent colorectal cancer (CRC) screening gaps, Guardant Health has launched a community grant program offering…
The 2025 Identity Theft Resource Center report confirms what many physician-owners are feeling: cyberattacks are no longer random — they’re…
UMass’ Division of Gastroenterology has completed its first Full-Thickness Resection Device (FTRD) procedure, marking an expansion in advanced endoscopic capabilities.…
Private equity firms are increasingly being forced to rethink their healthcare strategies…
Thought Leadership
At the Cleveland Clinic, the newly formed Endorobotics Collaborative signals a shift…
What to Do When Procedures Are No Longer Enough An upcoming book…
Gastroenterology is rapidly becoming a focal point for innovation, with AI, robotics,…
ARTIFICIAL INTELLIGENCE (AI)
Tech & Innovation
Neptune Medical reported positive first-in-human results for its Triton Robotic Endoscopy system, with a 50-patient study showing no adverse events and 100% cecal intubation during colonoscopy…
Exponential Tech
Neptune Medical reported positive first-in-human results for its Triton Robotic Endoscopy system,…